Clinical Study of Umbilical Cord Tissue Mesenchymal Stem Cells (UC-MSC) for Treatment of Osteoarthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Allogeneic human umbilical cord tissue-derived stem cells injected intravenously (IV) once per day for 3 days or once intra-articularly are a safe and will induce a therapeutic effect in osteoarthritis (OA) patients.
Epistemonikos ID: ec187e248a167bbdc836f36443c6a937799d2c83
First added on: May 12, 2024